[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Companion Animals Medicines and Vaccines-China Market Status and Trend Report 2015-2026

May 2020 | 149 pages | ID: C9274F06A19DEN
MIReports Co., Limited

US$ 2,980.00

E-mail Delivery (PDF)

Download PDF Leaflet

Wire Transfer
Checkout Later
Need Help? Ask a Question
Report Summary

Companion Animals Medicines and Vaccines-China Market Status and Trend Report 2015-2026 offers a comprehensive analysis on Companion Animals Medicines and Vaccines industry, standing on the readers’ perspective, delivering detailed market data and penetrating insights. No matter the client is industry insider, potential entrant or investor, the report will provides useful data and information. Key questions answered by this report include:

Whole China and Regional Market Size of Companion Animals Medicines and Vaccines 2015-2019, and development forecast 2020-2026
Main market players of Companion Animals Medicines and Vaccines in China, with company and product introduction, position in the Companion Animals Medicines and Vaccines market
Market status and development trend of Companion Animals Medicines and Vaccines by types and applications
Cost and profit status of Companion Animals Medicines and Vaccines, and marketing status
Market growth drivers and challenges

The report segments the China Companion Animals Medicines and Vaccines market as:

China Companion Animals Medicines and Vaccines Market: Regional Segment Analysis (Regional Consumption Volume, Consumption Volume, Revenue and Growth Rate 2015-2026):
North China
Northeast China
East China
Central & South China
Southwest China
Northwest China

China Companion Animals Medicines and Vaccines Market: Product Type Segment Analysis (Consumption Volume, Average Price, Revenue, Market Share and Trend 2015-2026):
Medicines
Vaccines

China Companion Animals Medicines and Vaccines Market: Application Segment Analysis (Consumption Volume and Market Share 2015-2026; Downstream Customers and Market Analysis)
Dogs
Cats
Other

China Companion Animals Medicines and Vaccines Market: Players Segment Analysis (Company and Product introduction, Companion Animals Medicines and Vaccines Sales Volume, Revenue, Price and Gross Margin):
Zoetis
Ceva
Elanco Animal Health
Boehringer Ingelheim
Dechra Veterinary Products
Merck Animal Health
Meiji
Virbac
Bayer Animal Health
Vetoquinol
Ouro Fino Saude
Parnell

In a word, the report provides detailed statistics and analysis on the state of the industry; and is a valuable source of guidance and direction for companies and individuals interested in the market.
CHAPTER 1 OVERVIEW OF COMPANION ANIMALS MEDICINES AND VACCINES

1.1 Definition of Companion Animals Medicines and Vaccines in This Report
1.2 Commercial Types of Companion Animals Medicines and Vaccines
  1.2.1 Medicines
  1.2.2 Vaccines
1.3 Downstream Application of Companion Animals Medicines and Vaccines
  1.3.1 Dogs
  1.3.2 Cats
  1.3.3 Other
1.4 Development History of Companion Animals Medicines and Vaccines
1.5 Market Status and Trend of Companion Animals Medicines and Vaccines 2015-2026
  1.5.1 China Companion Animals Medicines and Vaccines Market Status and Trend 2015-2026
  1.5.2 Regional Companion Animals Medicines and Vaccines Market Status and Trend 2015-2026

CHAPTER 2 CHINA MARKET STATUS AND FORECAST BY REGIONS

2.1 Market Status of Companion Animals Medicines and Vaccines in China 2015-2019
2.2 Consumption Market of Companion Animals Medicines and Vaccines in China by Regions
  2.2.1 Consumption Volume of Companion Animals Medicines and Vaccines in China by Regions
  2.2.2 Revenue of Companion Animals Medicines and Vaccines in China by Regions
2.3 Market Analysis of Companion Animals Medicines and Vaccines in China by Regions
  2.3.1 Market Analysis of Companion Animals Medicines and Vaccines in North China 2015-2019
  2.3.2 Market Analysis of Companion Animals Medicines and Vaccines in Northeast China 2015-2019
  2.3.3 Market Analysis of Companion Animals Medicines and Vaccines in East China 2015-2019
  2.3.4 Market Analysis of Companion Animals Medicines and Vaccines in Central & South China 2015-2019
  2.3.5 Market Analysis of Companion Animals Medicines and Vaccines in Southwest China 2015-2019
  2.3.6 Market Analysis of Companion Animals Medicines and Vaccines in Northwest China 2015-2019
2.4 Market Development Forecast of Companion Animals Medicines and Vaccines in China 2020-2026
  2.4.1 Market Development Forecast of Companion Animals Medicines and Vaccines in China 2020-2026
  2.4.2 Market Development Forecast of Companion Animals Medicines and Vaccines by Regions 2020-2026

CHAPTER 3 CHINA MARKET STATUS AND FORECAST BY TYPES

3.1 Whole China Market Status by Types
  3.1.1 Consumption Volume of Companion Animals Medicines and Vaccines in China by Types
  3.1.2 Revenue of Companion Animals Medicines and Vaccines in China by Types
3.2 China Market Status by Types in Major Countries
  3.2.1 Market Status by Types in North China
  3.2.2 Market Status by Types in Northeast China
  3.2.3 Market Status by Types in East China
  3.2.4 Market Status by Types in Central & South China
  3.2.5 Market Status by Types in Southwest China
  3.2.6 Market Status by Types in Northwest China
3.3 Market Forecast of Companion Animals Medicines and Vaccines in China by Types

CHAPTER 4 CHINA MARKET STATUS AND FORECAST BY DOWNSTREAM INDUSTRY

4.1 Demand Volume of Companion Animals Medicines and Vaccines in China by Downstream Industry
4.2 Demand Volume of Companion Animals Medicines and Vaccines by Downstream Industry in Major Countries
  4.2.1 Demand Volume of Companion Animals Medicines and Vaccines by Downstream Industry in North China
  4.2.2 Demand Volume of Companion Animals Medicines and Vaccines by Downstream Industry in Northeast China
  4.2.3 Demand Volume of Companion Animals Medicines and Vaccines by Downstream Industry in East China
  4.2.4 Demand Volume of Companion Animals Medicines and Vaccines by Downstream Industry in Central & South China
  4.2.5 Demand Volume of Companion Animals Medicines and Vaccines by Downstream Industry in Southwest China
  4.2.6 Demand Volume of Companion Animals Medicines and Vaccines by Downstream Industry in Northwest China
4.3 Market Forecast of Companion Animals Medicines and Vaccines in China by Downstream Industry

CHAPTER 5 MARKET DRIVING FACTOR ANALYSIS OF COMPANION ANIMALS MEDICINES AND VACCINES

5.1 China Economy Situation and Trend Overview
5.2 Companion Animals Medicines and Vaccines Downstream Industry Situation and Trend Overview

CHAPTER 6 COMPANION ANIMALS MEDICINES AND VACCINES MARKET COMPETITION STATUS BY MAJOR PLAYERS IN CHINA

6.1 Sales Volume of Companion Animals Medicines and Vaccines in China by Major Players
6.2 Revenue of Companion Animals Medicines and Vaccines in China by Major Players
6.3 Basic Information of Companion Animals Medicines and Vaccines by Major Players
  6.3.1 Headquarters Location and Established Time of Companion Animals Medicines and Vaccines Major Players
  6.3.2 Employees and Revenue Level of Companion Animals Medicines and Vaccines Major Players
6.4 Market Competition News and Trend
  6.4.1 Merger, Consolidation or Acquisition News
  6.4.2 Investment or Disinvestment News
  6.4.3 New Product Development and Launch

CHAPTER 7 COMPANION ANIMALS MEDICINES AND VACCINES MAJOR MANUFACTURERS INTRODUCTION AND MARKET DATA

7.1 Zoetis
  7.1.1 Company profile
  7.1.2 Representative Companion Animals Medicines and Vaccines Product
  7.1.3 Companion Animals Medicines and Vaccines Sales, Revenue, Price and Gross Margin of Zoetis
7.2 Ceva
  7.2.1 Company profile
  7.2.2 Representative Companion Animals Medicines and Vaccines Product
  7.2.3 Companion Animals Medicines and Vaccines Sales, Revenue, Price and Gross Margin of Ceva
7.3 Elanco Animal Health
  7.3.1 Company profile
  7.3.2 Representative Companion Animals Medicines and Vaccines Product
  7.3.3 Companion Animals Medicines and Vaccines Sales, Revenue, Price and Gross Margin of Elanco Animal Health
7.4 Boehringer Ingelheim
  7.4.1 Company profile
  7.4.2 Representative Companion Animals Medicines and Vaccines Product
  7.4.3 Companion Animals Medicines and Vaccines Sales, Revenue, Price and Gross Margin of Boehringer Ingelheim
7.5 Dechra Veterinary Products
  7.5.1 Company profile
  7.5.2 Representative Companion Animals Medicines and Vaccines Product
  7.5.3 Companion Animals Medicines and Vaccines Sales, Revenue, Price and Gross Margin of Dechra Veterinary Products
7.6 Merck Animal Health
  7.6.1 Company profile
  7.6.2 Representative Companion Animals Medicines and Vaccines Product
  7.6.3 Companion Animals Medicines and Vaccines Sales, Revenue, Price and Gross Margin of Merck Animal Health
7.7 Meiji
  7.7.1 Company profile
  7.7.2 Representative Companion Animals Medicines and Vaccines Product
  7.7.3 Companion Animals Medicines and Vaccines Sales, Revenue, Price and Gross Margin of Meiji
7.8 Virbac
  7.8.1 Company profile
  7.8.2 Representative Companion Animals Medicines and Vaccines Product
  7.8.3 Companion Animals Medicines and Vaccines Sales, Revenue, Price and Gross Margin of Virbac
7.9 Bayer Animal Health
  7.9.1 Company profile
  7.9.2 Representative Companion Animals Medicines and Vaccines Product
  7.9.3 Companion Animals Medicines and Vaccines Sales, Revenue, Price and Gross Margin of Bayer Animal Health
7.10 Vetoquinol
  7.10.1 Company profile
  7.10.2 Representative Companion Animals Medicines and Vaccines Product
  7.10.3 Companion Animals Medicines and Vaccines Sales, Revenue, Price and Gross Margin of Vetoquinol
7.11 Ouro Fino Saude
  7.11.1 Company profile
  7.11.2 Representative Companion Animals Medicines and Vaccines Product
  7.11.3 Companion Animals Medicines and Vaccines Sales, Revenue, Price and Gross Margin of Ouro Fino Saude
7.12 Parnell
  7.12.1 Company profile
  7.12.2 Representative Companion Animals Medicines and Vaccines Product
  7.12.3 Companion Animals Medicines and Vaccines Sales, Revenue, Price and Gross Margin of Parnell

CHAPTER 8 UPSTREAM AND DOWNSTREAM MARKET ANALYSIS OF COMPANION ANIMALS MEDICINES AND VACCINES

8.1 Industry Chain of Companion Animals Medicines and Vaccines
8.2 Upstream Market and Representative Companies Analysis
8.3 Downstream Market and Representative Companies Analysis

CHAPTER 9 COST AND GROSS MARGIN ANALYSIS OF COMPANION ANIMALS MEDICINES AND VACCINES

9.1 Cost Structure Analysis of Companion Animals Medicines and Vaccines
9.2 Raw Materials Cost Analysis of Companion Animals Medicines and Vaccines
9.3 Labor Cost Analysis of Companion Animals Medicines and Vaccines
9.4 Manufacturing Expenses Analysis of Companion Animals Medicines and Vaccines

CHAPTER 10 MARKETING STATUS ANALYSIS OF COMPANION ANIMALS MEDICINES AND VACCINES

10.1 Marketing Channel
  10.1.1 Direct Marketing
  10.1.2 Indirect Marketing
  10.1.3 Marketing Channel Development Trend
10.2 Market Positioning
  10.2.1 Pricing Strategy
  10.2.2 Brand Strategy
  10.2.3 Target Client
10.3 Distributors/Traders List

CHAPTER 11 REPORT CONCLUSION

CHAPTER 12 RESEARCH METHODOLOGY AND REFERENCE

12.1 Methodology/Research Approach
  12.1.1 Research Programs/Design
  12.1.2 Market Size Estimation
  12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
  12.2.1 Secondary Sources
  12.2.2 Primary Sources
12.3 Reference


More Publications